medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2023, Number 3

<< Back Next >>

Acta Med 2023; 21 (3)

Takayasu arteritis

Domínguez CLG, Arellano AJG, Arellano GG

Language: Spanish
References: 26
Page: 262-267
PDF size: 197.86 Kb.


ABSTRACT

Takayasu arteritis is an inflammatory disease of medium and large-caliber arteries, with a predilection for the aorta and its branches. The lesions produced by the inflammatory process can be stenotic, occlusive, or aneurysmal. Vascular changes lead to the main complications. Although the management of Takayasu arteritis is improving, the diagnosis is usually delayed. Although the broader use of non-invasive imaging has improved, clinicians are still responsible for considering the earlier diagnosis. A review of the current situation is carried out. Understanding of the pathogenesis of the disease remains poor. However, recent genetic data and identifying pathogenic cytokines may facilitate the search for biomarkers distinguishing between active and inactive disease and inflammatory and non-inflammatory arterial remodeling. Imaging is critical for diagnosis, evaluation, and disease progression. Reliance on Steroid therapy remains too high. However, the impact of combination immunosuppressive therapy is now recognized, biological therapies are becoming more widely available, and new agents show promise, trying to modify morbidity and mortality.


REFERENCES

  1. Jennette JC, Falk RJ, Bacon PA et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013; 65 (1): 1-11.

  2. Fries JF, Hunder GG, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990; 33 (8): 1135-1136.

  3. Sugiyama K, Ijiri S, Tagawa S, Shimizu K. Takayasu disease on the centenary of its discovery. Jpn J Ophthalmol. 2009; 53 (2): 81-91. doi: 10.1007/s10384-009-0650-2.

  4. Dabahue J, Reyes AP. Takayasu arteritis in Mexico: a 38-year clinical perspective through literature review. Inter J Cardiol. 1996; 54 Supp1: S87-S93. Available in: doi.org/10.1016/0167-5273(96)02642-3.

  5. Soto ME, Espinola N, Flores-Suarez LF, Reyes PA. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008; 26 (3 Suppl 49): S9-15.

  6. Alnabwani D, Patel P, Kata P et al. The epidemiology and clinical manifestations of Takayasu arteritis: a descriptive study of case reports. Cureus. 2021; 13 (9): e17998. doi: 10.7759/cureus.17998.

  7. Numano F, Kobayashi Y. Takayasu arteritis-beyond pulselessness. Intern Med. 1999; 38 (3): 226-232.

  8. Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu arteritis in India. Int J Cardiol. 1996; 54 Suppl: S111-116.

  9. Tombetti E, Mason CJ. Takayasu arteritis: advanced understanding is leading to new horizons. Rheumatology. 2019: 58: 206-219. Available in: https://doi.org/10.1093 /rheumatology/key040

  10. Chikashi Terao. Revisited HLA and non-HLA genetics of Takayasu arteritis--where are we? J Hum Genet. 2016; 61: 27-32. doi: 10.1038/jhg.2015.87.

  11. Seyahi E. Takayasu arteritis: an update. Curr Opin Rheumatol. 2017; 29: 51-56.

  12. Roberts RF, Diamond SH, Monteagudo AL, Shah AP et al. Takayasu Arteritis clinical presentation. Med Sacape Drugs Diseases Rheum. Updated: 2022, Sep 21.

  13. Ozen S, Pistorio A, Lusan SM et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010; 69: 798-806.

  14. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS: Takayasu arteritis. Ann Intern Med. 1994; 120: 919-929. doi: 10.7326/0003-4819-120-11-199406010-00004.

  15. Tombetti E, Zia A, Gopalan D et al. FRI0258 A novel MRI-based longitudinal scoring system for arterial involvement in large-vessel vasculitis. Ann Rheum Dis. 2015; 74: 518-523. Available in: http://dx.doi.org/10.1136/annrheumdis-2015-eular.6265

  16. Barra L, Kanji T, Malette J, Pagnoux C, CanVasc. Imaging modalities for the diagnosis and disease activity assessment of Takayasu's arteritis: a systematic review and meta-analysis. Autoimmun Rev. 2018; 17: 175-187.

  17. Ryan C, Barbour A, Burke L, Sheppard MN. Non-infectious aortitis of the ascending aorta: a histological and clinical correlation of 71 cases including overlap with medial degeneration and atheroma-a challenge for the pathologist. J Clin Pathol. 2015; 68: 898-904.

  18. Maz M, Chung SA, Abril A et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol. 2021; 73 (8): 1349-1365.

  19. Nakaoka Y, Isobe M, Takei S et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis. 2018; 77: 348-354.

  20. Regola F, Uzzo M, Toniati P, Trezzi B, Sinico RA, Franceschini F. Novel therapies in Takayasu arteritis. Front Med (Lausanne). 2022; 8: 814075. doi: 10.3389/fmed.2021.814075.

  21. Youngstein T, Peters JE, Hamdulay SS et al. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-a and IL-6 receptor targeted therapies in refractory Takayasu arteritis. Clin Exp Rheumatol. 2014; 32 (3 Suppl 82): S11-18.

  22. Youngstein T, Tombetti E, Mukherjee J et al. FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease. JACC Cardiovasc Imaging 2017; 10: 1042-1052.

  23. Mason JC. Takayasu arteritis: surgical interventions. Curr Opin Rheumatol. 2015; 27: 45-52. doi: 10.1097/bor.0000000000000127.

  24. Comarmond C, Biard L, Lambert M et al. Long-term outcomes and prognostic factors of complications in Takayasu's arteritis: a multicenter study of 318 patients. Circulation. 2017; 136: 1114-1122.

  25. Hellmann D. Kelley's textbook of rheumatology. Nebraska: Elsevier; 2013. pp. 1595-1616.

  26. Kato Y, Terashima M, Ohigashi H et al. Vessel wall inflammation of Takayasu arteritis detected by contrast-enhanced magnetic resonance imaging: association with disease distribution and activity. PLoS ONE. 2015; 10 (12): e0145855. Available in: https://doi.org/10.1371/journal.pone.0145855




2020     |     www.medigraphic.com